STS offers on-demand webinars on a variety of topics, allowing you to learn new content when it is most convenient for you. For older programs, visit the 2021 STS Webinar Series playlist on YouTube.
STS is pleased to co-present this free webinar on the Advances in Surgery channel. Creation of a free account on the AIS site is required to view the program.
Watch STS President Thomas MacGillivray and DEI consultant James Pogue discuss diversity, equity, and inclusion. The video includes Q&A, insights from moderators, and an update on the Society’s efforts to bolster its commitment to DEI. Viewers will come away with a deeper understanding of DEI, and the opportunities and challenges in advancing a culture of inclusivity within STS and the specialty.
Moderators
Thomas E. MacGillivray, MD
STS President
Washington, DC
James Pogue, PhD
President and CEO, JP Enterprises
Dallas, Texas
Cardiothoracic surgeons and trainees who are underrepresented in medicine (URiM) will discuss challenges and successes they’ve experienced throughout their careers. Additionally, the panel will share what they have learned from these experiences and how to apply those lessons toward supporting other surgeons from underrepresented groups.
Aortic regurgitation is an undertreated condition, often because patients are not referred in a timely fashion for intervention. During this STS webinar, attendees will hear from an expert panel on the evidence base for timing of intervention as well as evolving treatment options. Conventional surgical aortic valve repair can be considered alongside the Ross procedure and transcatheter interventions with dedicated devices. Webinar participants will be better informed on how to treat this patient population.
Diversity in the physician workforce is a key component of delivering the best care to our increasingly heterogeneous patient population. The experience of Asians in cardiothoracic surgery is not well known. With a paucity of published evidence, the webinar panel will introduce the topic through the lived experience of Asians in the specialty. The discussion will explore:
The management of stage IIIA non-small cell lung cancer (NSCLC) is evolving in the era of immune checkpoint inhibitor therapy. In the past, there has been a great deal of controversy regarding the optimal management of patients with N2 nodal metastasis at the time of diagnosis of NSCLC. There are some new questions to address when considering the results of the Checkmate 816 and the NADIM II clinical trials which demonstrated improved disease-free survival and overall survival with neoadjuvant combined chemotherapy and Nivolumab.
Recent approvals by the U.S. Food and Drug Administration (FDA) have made available two new technologies for treating aortic disease. The GORE® TAG® Thoracic Branch Endoprosthesis (TBE) is single-branch aortic stent graft that provides an off-the-shelf solution for patients that need zone II aortic coverage and obviates the need for prior left subclavian revascularization. The Thoraflex Hybrid Frozen Elephant Trunk (FET) device is a pre-mated surgical graft and an aortic stent graft to facilitate single-stage treatment of arch and proximal descending aortic pathologies.
Last year, the lung transplant community was excited by reports from Toronto General Hospital of successful lung transplants with seemingly improved perioperative outcomes compared to standard of care ice storage, after donor lungs were stored for up to 16 hours at 10 degrees Celsius. While a clinical trial is ongoing, preclinical evidence suggests that organ storage may be successfully extended to more than a day, with intermittent normothermic ex-vivo lung perfusion (EVLP) utilization. Is it time to consider lung transplantation as a semi-elective procedure?
During Peer Review Week, Annals Editor-in-Chief Joanna Chikwe, MD, FRCS, is joined by a panel of editors, editorial board members, and experts to highlight touchstones of publication ethics and how research drives quality.
Procedures to evaluate lymph nodes before lung cancer therapy, including endobronchial guided nodal aspiration and mediastinoscopy, can help diagnose and stage the patient effectively. Research findings demonstrate, however, that these procedures are underutilized overall or employed in a highly variable fashion. In this STS webinar, an expert panel of pulmonologists and thoracic surgeons discusses the changing role of pretreatment nodal staging to include diagnosis, staging, and acquisition of sufficient tissue for biomarker testing.
Recent data from two large randomized studies of segmentectomy for small (≤2cm) peripheral non-small cell lung cancer (NSCLC) treatment suggest a change is coming in the standard of care. In this STS webinar, an expert panel discusses how evolving robotic and imaging technologies are changing the landscape of treatment for early stage NSCLC. The session features a review of recent trials, advanced imaging, complex segmentectomy videos, and case scenarios.
